|
|
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2 |
| 5KL2TR002490-05 |
|
NCATS |
2022 |
|
|
Institutional Career Development Core |
| 5KL2TR002530-05 |
|
NCATS |
2022 |
|
|
Institutional Career Development Core |
| 5KL2TR002534-05 |
|
NCATS |
2022 |
|
|
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform |
| 5U01TR003715-02 |
|
NCATS |
2022 |
|
|
Washington Entrepreneurial Research Evaluation and Commercialization Hub |
| 5U01HL152401-04 |
|
NHLBI |
2022 |
|
|
Parenchymal border macrophages in AD and CAA |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Interplay between meningeal lymphatics, high-density lipoproteins and border macrophages in cerebral amyloid angiopathy |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Project 3 - Astrocytic glutamate dysregulation in AD and VCID |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
Project 2 - Astrocytic insulin signaling and AD |
| 1P01AG078116-01 |
|
NIA |
2022 |